Open access
116
Views
4
CrossRef citations to date
0
Altmetric
Original Research
Collaboration in pharmacovigilance: lamotrigine and fatal severe cutaneous adverse reactions – a review of spontaneous reports
Neil Brickel1 Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, Uxbridge, Middlesex, UKCorrespondence[email protected]
, Haris Shaikh1 Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, Uxbridge, Middlesex, UK
, Andrew Kirkham2 Classic and Established Products, GlaxoSmithKline, Brentford, Middlesex, UK
, Greg Davies1 Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, Uxbridge, Middlesex, UK
, Michelle Chalker1 Global Clinical Safety and Pharmacovigilance, GlaxoSmithKline, Uxbridge, Middlesex, UK
& Pascal Yoshida3 Clinical Safety and Post-marketing Surveillance, GlaxoSmithKline KK, Tokyo, Japan
Pages 897-903
|
Published online: 20 Jul 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.